ScholarIQanswers from OpenAlex & ORCID
John F. DiPersio
ResearcherPublications, citations & collaboration network
John F. DiPersio is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does John F. DiPersio have?
ScholarIQindexed works
John F. DiPersio has 1,364 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does John F. DiPersio have?
ScholarIQcitation count
John F. DiPersio has 90,432 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of John F. DiPersio?
ScholarIQh-index
John F. DiPersio has an h-index of 126 in OpenAlex.
What is the i10-index of John F. DiPersio?
ScholarIQi10-index
John F. DiPersio has an i10-index of 505 in OpenAlex.
What is the ORCID of John F. DiPersio?
ScholarIQorcid
The ORCID for John F. DiPersio is on the source record.
What is the OpenAlex record for John F. DiPersio?
ScholarIQopenalex
The OpenAlex for John F. DiPersio is on the source record.
What are the most-cited papers on John F. DiPersio?
ScholarIQmost cited works
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
John R. Wingard, Shelly L. Carter, Thomas J. Walsh, Joanne Kurtzberg, Trudy N. Small, Lindsey R. Baden, Iris D. Gersten, Adam Mendizabal, Helen Leather, Dennis L. Confer, Richard T. Maziarz, Edward A. Stadtmauer, Javier Bolaños‐Meade, J. Martin Brown, John F. DiPersio, Michael Boeckh, Kieren A. Marr
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, R. S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, E. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Azra Raza, Kris Vaddi, William Sun, Wei Peng, V. Sandor, Hagop M. Kantarjian, For the COMFORT-I investigators
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani, John E. Godwin, Martha Arellano, Kendra Sweet, Ashkan Emadi, Farhad Ravandi, Harry P. Erba, Michael Byrne, Laura C. Michaelis, Max S. Topp, Norbert Vey, Fabio Ciceri, Matteo Giovanni Carrabba, Stefania Paolini, Gerwin Huls, Mojca Jongen‐Lavrencic, Martin Wermke, Patrice Chevallier, Emmanuel Gyan, Christian Récher, Patrick J. Stiff, Kristen Pettit, Bob Löwenberg, S. Church, Erica Anderson, Jayakumar Vadakekolathu, Marianne Santaguida, Michael P. Rettig, John Muth, Teia Curtis, Erin Fehr, Kuo Guo, Jian Zhao, Ouiam Bakkacha, Kenneth Jacobs, Kathy Tran, Patrick Kaminker, Maya Kostova, Ezio Bonvini, Roland B. Walter, Jan Davidson‐Moncada, Sergio Rutella, John F. DiPersio
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis
Richard A. Nash, James D. Bowen, Peter A. McSweeney, Steven Z. Pavletic, Kenneth R. Maravilla, Man-soo Park, Jan Storek, Keith M. Sullivan, Jinan Al-Omaishi, John R. Corboy, John F. DiPersio, George E. Georges, Theodore A. Gooley, Leona Holmberg, C.F. LeMaistre, Kate Ryan, Harry Openshaw, Julie Sunderhaus, Rainer Storb, Joseph R. Zunt, George H. Kraft
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia
Mark R. Litzow, Sergey Tarima, Waleska S. Pérez, Brian J. Bolwell, Mitchell S. Cairo, Bruce M. Camitta, Corey Cutler, Marcos de Lima, John F. DiPersio, Robert Peter Gale, Armand Keating, Hillard M. Lazarus, Selina M. Luger, David I. Marks, Richard T. Maziarz, Philip L. McCarthy, Marcelo C. Pasquini, Gordon L. Phillips, J. Douglas Rizzo, Jorge Sierra, Martin S. Tallman, Daniel J. Weisdorf